Life Sciences Patent Network Meeting, Boston 26 April 2018 – a report from the cutting edge
Yesterday I attended LSPN’s spring North America meeting, and what a stimulating and valuable event it was. Gathered together was a...
Contributors
-
Trade Mark Attorney -
Trainee Trade Mark Attorney -
Partner -
Partner -
-
Senior Associate -
Senior Associate -
Senior Associate -
Trade Mark Assistant -
Associate Patent Attorney -
Trade Mark Assistant -
Technical Assistant -
Marketing and Communications Manager -
Trade Mark Assistant -
Partner -
Associate
Dehns Insights Archive
- November 2019 (4)
- October 2019 (1)
- August 2019 (1)
- July 2019 (2)
- June 2019 (2)
- April 2019 (4)
- March 2019 (2)
- February 2019 (3)
- January 2019 (6)
- December 2018 (2)
- November 2018 (8)
- October 2018 (3)
- September 2018 (7)
- August 2018 (3)
- July 2018 (3)
- June 2018 (6)
- May 2018 (7)
- April 2018 (14)
- March 2018 (12)
- February 2018 (8)
- January 2018 (8)
- December 2017 (8)
- November 2017 (3)
- October 2017 (12)
- September 2017 (8)
- August 2017 (6)
- July 2017 (5)
- June 2017 (7)
- May 2017 (5)
- April 2017 (3)
- March 2017 (5)
- February 2017 (5)
- January 2017 (3)
- December 2016 (1)
- November 2016 (7)
- October 2016 (7)
- September 2016 (12)
- August 2016 (9)
- July 2016 (6)
- June 2016 (13)
- May 2016 (34)
Specific and precise criteria for SPCs proposed by Advocate General are anything but
When is a product "protected" by a basic patent for the purpose of Article 3(a) of the SPC Regulation? This question has kept the courts...
UK Ratifies UPC Agreement
In a speech to mark World IP Day, the British Government's IP Minister, Sam Gyimah, announced that the UK has ratified the Agreement on a...
Patenting software seminar - Thursday 10 May
The patent system exists to encourage and reward innovation. It does this by preventing people from copying others’ innovative ideas, in...
My highlights of the 5th Biennial Biosimilars and Biobetters Congress
This time last week I had the privilege of attending the 5th Biennial Biosimilars and Biobetters Congress in London. The conference...
Liverpool FC looking for win in US
Last month, we reported on the curious case of lower-league football team Dulwich Hamlet Football Club and the somewhat bizarre decision...
5 things I learned at the 5th Annual Peptides Congress
It was a privilege to attend the 5th Annual Peptides Congress in London yesterday and interact with so many experts in this field. Here...
Biosimilars Congress 2018 -Patenting of Biosimilars and Biobetters
Today we are exhibiting at the 5th Biennial Biosimilars and Biobetters Congress in London.
It is great to be part of an event that...
When inventions come to life
Most often, the invention in a patent application is for early stage, sometimes speculative, research which is yet to be fully realised....
5th Biennial Biosimilars & Biobetters Congress 2018
I’m really looking forward to next week’s Biosimilars and Biobetters Congress in London. The organisers have put together a high-powered...
Chinese companies increase use of international patent system
Following the release of the annual statistics from the European Patent Office (EPO), the World Intellectual Property Organisation (WIPO)
Patenting antibodies
Antibody technology has advanced a long way since the early days of Kohler & Milstein’s antibody-secreting murine hybridomas. Whilst...
The patenting of immoral inventions
Most countries have patent laws which prohibit − directly or indirectly − the patenting of immoral inventions. However, the concept of...
Fowl Play in Reading?
Every now and then a story pops up in the papers in which a large company is accused of using its trade mark rights to bully a smaller...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
-
Search site
-
Contact our offices